Finland's healthcare system is renowned for its digitalization and preventative approach. In the context of chronic disease management, there is a high demand for a continuous glucose monitor that can withstand the extreme temperature fluctuations of the Finnish climate, ensuring that sensors remain accurate from the humid summers to the freezing arctic winters.
The Finnish market is characterized by a strong preference for evidence-based medical devices. Users are increasingly moving away from painful finger-pricks toward a glucose monitor patch, which allows for a more discreet and comfortable experience, aligning with the Finnish value of modesty and practical functionality.
Furthermore, the integration of healthcare data into the national Kanta system requires monitoring devices to possess high interoperability. This drives the adoption of an advanced continous glucose monitor that can securely transmit data to multidisciplinary care teams across various health districts.
